Search research articles
Contact Us
Filters
Showing results (1181-1190 of 2,791) with videos related to
Page
of 280
Sort By:
Cytotherapy
|
March 14, 2021
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition
Jacques Galipeau, Mauro Krampera, Katarina Leblanc, et al.
Cytotherapy
|
March 6, 2021
Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event simulation
Ching Lam, Edward Meinert, Aidong Yang, et al.
Cytotherapy
|
February 2, 2021
Endoscopic atomization of mesenchymal stromal cells: in vitro study for local cell therapy of the lungs
Anja Lena Thiebes, Franziska E Uhl, Marie Hauser, et al.
Cytotherapy
|
January 18, 2022
Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies
Harinad B Maganti, Aidan M Kirkham, Adrian J M Bailey, et al.
Cytotherapy
|
December 5, 2021
Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation
Rutvij A Khanolkar, Rehan M Faridi, Megan Kinzel, et al.
Cytotherapy
|
October 23, 2022
Comparison of guidelines for biological ancillary materials used for the manufacture of gene and cellular therapy products in Asia
Toshimitsu Tanaka, Keiji Yoshimura, Ryan Chang, et al.
Cytotherapy
|
October 16, 2022
CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilities
Fabiola Nardi Bauer, Tobias Tertel, Oumaima Stambouli, et al.
Cytotherapy
|
September 3, 2022
γc cytokine-aided crosstalk between dendritic cells and natural killer cells together with doxorubicin induces a healer response in experimental lymphoma by downregulating FOXP3 and programmed cell death protein 1
Ranjeet Singh, Uttam Gupta, Prateek Srivastava, et al.
Cytotherapy
|
November 1, 2022
Identification of marker genes to monitor residual iPSCs in iPSC-derived products
Myriam Lemmens, Juliane Perner, Leon Potgeter, et al.
Cytotherapy
|
November 5, 2022
Adverse effect of donor-specific anti-human leukocyte antigen (HLA) antibodies directed at HLA-DP/-DQ on engraftment in cord blood transplantation
Tomoyasu Jo, Yasuyuki Arai, Kazuo Hatanaka, et al.
Page
of 280
Search research articles
Search
Showing results (1181-1190 of 2,791) with videos related to
Sort By:
Page
of 280
Cytotherapy
|
March 14, 2021
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition
Jacques Galipeau, Mauro Krampera, Katarina Leblanc, et al.
Cytotherapy
|
March 6, 2021
Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event simulation
Ching Lam, Edward Meinert, Aidong Yang, et al.
Cytotherapy
|
February 2, 2021
Endoscopic atomization of mesenchymal stromal cells: in vitro study for local cell therapy of the lungs
Anja Lena Thiebes, Franziska E Uhl, Marie Hauser, et al.
Cytotherapy
|
January 18, 2022
Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies
Harinad B Maganti, Aidan M Kirkham, Adrian J M Bailey, et al.
Cytotherapy
|
December 5, 2021
Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation
Rutvij A Khanolkar, Rehan M Faridi, Megan Kinzel, et al.
Cytotherapy
|
October 23, 2022
Comparison of guidelines for biological ancillary materials used for the manufacture of gene and cellular therapy products in Asia
Toshimitsu Tanaka, Keiji Yoshimura, Ryan Chang, et al.
Cytotherapy
|
October 16, 2022
CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilities
Fabiola Nardi Bauer, Tobias Tertel, Oumaima Stambouli, et al.
Cytotherapy
|
September 3, 2022
γc cytokine-aided crosstalk between dendritic cells and natural killer cells together with doxorubicin induces a healer response in experimental lymphoma by downregulating FOXP3 and programmed cell death protein 1
Ranjeet Singh, Uttam Gupta, Prateek Srivastava, et al.
Cytotherapy
|
November 1, 2022
Identification of marker genes to monitor residual iPSCs in iPSC-derived products
Myriam Lemmens, Juliane Perner, Leon Potgeter, et al.
Cytotherapy
|
November 5, 2022
Adverse effect of donor-specific anti-human leukocyte antigen (HLA) antibodies directed at HLA-DP/-DQ on engraftment in cord blood transplantation
Tomoyasu Jo, Yasuyuki Arai, Kazuo Hatanaka, et al.
Page
of 280